Session (CTI)

ISSUE: As health technology assessment and value assessment frameworks increasingly incorporate expanded value measures, gaps remain in how these elements influence real-world decision making. Hospital technology adoption decisions for medical devices and diagnostics (MDD) may favor short-term value associated with the index event, which may limit the extent to which expanded value frameworks can shape patient access to innovation. This issue panel will examine opportunities to better align expanded value measures with hospital-level adoption and procurement decision making for MDD and how hospital decision-making processes can better reflect long-term patient and health system value. OVERVIEW: Health technology assessment and value assessment frameworks are increasingly incorporating expanded value measures that consider patient-centered outcomes and long-term health impacts. MDD value is often generated downstream through improved long-term outcomes, reduced complications, and improved quality of life rather than the index event itself. Hospitals may prioritize short-term value over longer-term patient and system value since they typically bear the upfront cost of technologies while some downstream benefits may emerge later or outside the hospital setting. In this context, long-term patient benefits may not always be fully captured at the point of hospital decision making. The moderator will open the session providing an overview of the issue to be discussed for 5 minutes, each speaker will provide their perspective for 15 minutes, and 10 minutes will be left for discussions and questions.